1. Home
  2. BNTC vs WALD Comparison

BNTC vs WALD Comparison

Compare BNTC & WALD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • WALD
  • Stock Information
  • Founded
  • BNTC 1995
  • WALD 1988
  • Country
  • BNTC United States
  • WALD United States
  • Employees
  • BNTC N/A
  • WALD N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • WALD Package Goods/Cosmetics
  • Sector
  • BNTC Health Care
  • WALD Consumer Discretionary
  • Exchange
  • BNTC Nasdaq
  • WALD Nasdaq
  • Market Cap
  • BNTC 335.5M
  • WALD 306.3M
  • IPO Year
  • BNTC N/A
  • WALD 2021
  • Fundamental
  • Price
  • BNTC $10.96
  • WALD $1.70
  • Analyst Decision
  • BNTC Strong Buy
  • WALD Strong Buy
  • Analyst Count
  • BNTC 5
  • WALD 5
  • Target Price
  • BNTC $26.00
  • WALD $5.16
  • AVG Volume (30 Days)
  • BNTC 82.9K
  • WALD 91.1K
  • Earning Date
  • BNTC 09-25-2025
  • WALD 08-26-2025
  • Dividend Yield
  • BNTC N/A
  • WALD N/A
  • EPS Growth
  • BNTC N/A
  • WALD N/A
  • EPS
  • BNTC N/A
  • WALD N/A
  • Revenue
  • BNTC N/A
  • WALD $273,868,000.00
  • Revenue This Year
  • BNTC N/A
  • WALD $14.78
  • Revenue Next Year
  • BNTC N/A
  • WALD $15.84
  • P/E Ratio
  • BNTC N/A
  • WALD N/A
  • Revenue Growth
  • BNTC N/A
  • WALD 25.55
  • 52 Week Low
  • BNTC $7.05
  • WALD $1.68
  • 52 Week High
  • BNTC $17.15
  • WALD $4.74
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 38.01
  • WALD 26.07
  • Support Level
  • BNTC $10.70
  • WALD $2.25
  • Resistance Level
  • BNTC $11.72
  • WALD $2.56
  • Average True Range (ATR)
  • BNTC 0.79
  • WALD 0.16
  • MACD
  • BNTC -0.01
  • WALD -0.08
  • Stochastic Oscillator
  • BNTC 16.57
  • WALD 2.27

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About WALD Waldencast plc

Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.

Share on Social Networks: